Xuyuan Liu

Title: Innovations of Xuyuan Liu in Pharmaceutical Research

Introduction

Xuyuan Liu is a prominent inventor based in Tianjin, China, known for his significant contributions to pharmaceutical research. He has been instrumental in developing innovative solutions that address critical health issues. With a total of three patents to his name, Liu's work focuses on enhancing drug efficacy and safety.

Latest Patents

One of Liu's latest patents is titled "Glucagon-derived peptide and use thereof." This invention provides a polypeptide derivative that exhibits a dual agonistic effect on GC/GLP-1 receptors. The polypeptide derivative effectively reduces blood glucose levels while promoting weight loss and improving body fat levels, demonstrating superior efficacy compared to single GLP-1 receptor agonists.

Another notable patent is for "Thienopyridine derivatives containing unsaturated aliphatic olefinic bond, preparation method and use thereof." This invention presents a compound that addresses clopidogrel resistance and severe hemorrhagic side effects associated with some drugs. The compound can be developed into an ADP receptor antagonist antiplatelet agent, offering clear therapeutic effects, enhanced stability, and reduced resistance.

Career Highlights

Xuyuan Liu is affiliated with the Tianjin Institute of Pharmaceutical Research Co., Ltd., where he continues to push the boundaries of pharmaceutical innovation. His research has led to advancements that not only improve drug formulations but also enhance patient safety and treatment outcomes.

Collaborations

Liu collaborates with esteemed colleagues, including Yuquan Li and Wei Liu, to further his research initiatives. Their combined expertise fosters a dynamic environment for innovation and development in the pharmaceutical field.

Conclusion

Xuyuan Liu's contributions to pharmaceutical research through his innovative patents highlight his commitment to improving healthcare solutions. His work exemplifies the impact of dedicated inventors in advancing medical science and enhancing patient care.